Semaglutide
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4035 publications
Oral semaglutide (Wegovy) for weight loss.
Journal: The Medical letter on drugs and therapeutics
Published: January 23, 2026
Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis.
Journal: Gastroenterologia y hepatologia
Published: January 22, 2026
Correction to "Cardiovascular Effectiveness of Semaglutide Versus Dulaglutide in Type 2 Diabetes".
Journal: Pharmacoepidemiology and drug safety
Published: January 22, 2026
Calculating cost per event avoided using a composite number needed to treat.
Journal: Journal of medical economics
Published: January 21, 2026
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have potential to transform health outcomes for persons with bipolar disorder, schizophrenia, major depressive disorder and other serious mental illnesses by lengthening healthspan and reducing excess and premature mortality.
Journal: Expert opinion on pharmacotherapy
Published: January 21, 2026
Annals On Call - Dulaglutide, Semaglutide, and Tirzepatide: How Do Gastrointestinal Adverse Effects Compare?
Journal: Annals of internal medicine
Published: January 19, 2026
What is "triple strength" Wegovy, and why has the MHRA approved it?
Journal: BMJ (Clinical research ed.)
Published: January 19, 2026
Semaglutide Augments Vascular Proliferation and Cardiac Performance in a Large Animal Model of Ischemic Cardiomyopathy.
Journal: American journal of physiology. Heart and circulatory physiology
Published: January 19, 2026
Gastroenterology and hepatology : what's new in 2025
Journal: Revue medicale suisse
Published: January 16, 2026
Last Updated: 02/24/2026